Glycoprotein VI
GP6proteinGPVI binds exposed collagen upon cap rupture or erosion, triggering platelet adhesion, activation, and thrombus propagation.
Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencehigh
RationaleCollagen receptor; platelet adhesion to exposed fibrous cap; prothrombotic target; s5 anchor.
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000088053
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I90
C — confounder / Type-II51
A — assay feasibility72
E — evidence strength33
T1DI (composite)17
Specificity differential (R−C)+39.7
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Human genetic evidence
0.018
Open Targets association (STEMI)
Literature evidence(20)
- Biomarkers of in vivo platelet activation in coronary artery disease: a systematic review and meta-analysis: communication from the SSC of the ISTH.Journal of thrombosis and haemostasis : JTH · 2025 · PMID 40685139 · doi
- Fibrin Monomer in Thrombosis and Haemostasis: A Clinical Biomarker and Beyond.International journal of molecular sciences · 2025 · PMID 41465254 · doi
- Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia.Platelets · 2024 · PMID 38845541 · doi
- Amplified inhibition of atherosclerotic plaque-induced platelet activation by glenzocimab with dual antiplatelet therapy.Journal of thrombosis and haemostasis : JTH · 2023 · PMID 37541591 · doi
- Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System.Arteriosclerosis, thrombosis, and vascular biology · 2021 · PMID 34496636 · doi
- Mice Lacking PECAM-1 and Ceacam1 Have Enhanced Platelet Secretion and Thrombus Growth: Novel Link with PAR4.Thrombosis and haemostasis · 2021 · PMID 34619794 · doi
- Glycoprotein VI - novel target in antiplatelet medication.Pharmacology & therapeutics · 2020 · PMID 32681846 · doi
- Atherosclerosis, myocardial infarction and primary hemostasis: Impact of platelets, von Willebrand factor and soluble glycoprotein VI.Thrombosis research · 2019 · PMID 31276978 · doi
- Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.Platelets · 2018 · PMID 29870296 · doi
- Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects.Blood advances · 2018 · PMID 30232085 · doi
- High-throughput elucidation of thrombus formation reveals sources of platelet function variability.Haematologica · 2018 · PMID 30545925 · doi
- ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.Journal of the American Heart Association · 2017 · PMID 28751543 · doi
- Plant-based Food Cyanidin-3-Glucoside Modulates Human Platelet Glycoprotein VI Signaling and Inhibits Platelet Activation and Thrombus Formation.The Journal of nutrition · 2017 · PMID 28855423 · doi
- Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches.Scientific reports · 2016 · PMID 28004756 · doi
- Collagen can selectively trigger a platelet secretory phenotype via glycoprotein VI.PloS one · 2014 · PMID 25116206 · doi
- Platelets in atherothrombosis--diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases.Current vascular pharmacology · 2012 · PMID 22338574 · doi
- Platelet and soluble glycoprotein VI - novel applications in diagnosis and therapy.Current drug targets · 2011 · PMID 21718237 · doi
- Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.American heart journal · 2008 · PMID 18585516 · doi
- Platelet glycoprotein VI: a novel marker for acute coronary syndrome.Seminars in thrombosis and hemostasis · 2007 · PMID 17340467 · doi
- PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets.Blood · 2003 · PMID 12893757 · doi